期刊文献+

UreB蛋白B细胞抗原表位快速筛选与鉴定 被引量:4

Rapid Screening and Identification of Dominant B Cell Epitopes of UreB Protein by Fluorescence Polarization Assay
下载PDF
导出
摘要 以幽门螺旋杆菌(Helicobacterpylori,Hp)主要抗原蛋白尿素酶B(ureaseB,UreB)为靶蛋白,建立一种新的B细胞抗原表位筛选与鉴定方法.运用Fmoc固相肽合成法合成11条HpUreB蛋白的单表位抗原肽片段,在其氨基端标记FITC荧光素,应用荧光偏振方法(fluorescencepolarization,FP)快速鉴定这些肽片段的抗原性,并通过FP法在大规模样品中快速筛选相应抗体滴度高、分布人群广的优势抗原表位肽.结果表明,合成的11条UreB蛋白线性抗原肽中,10条具有较强的抗原性,其中No.2、No.5和No.11抗原肽相应的特异性抗体在感染Hp的人群中分布较广,抗体滴度较高,为UreB的优势抗原表位肽.对抗原表位进行多参数综合分析与设计,通过FP技术快速鉴定抗原肽,并筛选优势抗原表位肽,对于疾病的抗原表位谱研究具有重要的意义,同时在疾病的诊断、分型及治疗中具有重要的应用前景. In order to develop a new method for screening and identification of dominant B cell epitopes using UreB protein as a target antigen 11 amino acid fragments from UreB protein of Helicobacter pylori (Hp) were synthesized by Fmoc solid phase peptide synthesis strategy, and fluorescein FITC was labeled to the N-terminals of all peptides respectively. The antigenicity of synthetic peptides is determined by analyzing the recognition and combination between peptides and standard antibody samples by fluorescence polarization (FP) immunoassay. In order to screen the dominant antigenic peptides, the FP assays were carried out to investigate the antibodies against 10 UreB synthetic peptides respectively in 159 UreB antibody-positive antiserum samples. There are 10 of 11 UreB synthetic peptides have distinct antigenicity by FP assay. The results showed that 3 out of the 10 antigenic peptides may be immunodominant, for the antibodies against them existed more widely among the samples and the antibody titers were higher than those of other peptides's. The methods for predicting and identifying epitopes are useful for epitope mapping, and the fluorescence polarized method for antibody immunoassay can be widely used in the diagnosis, typing and therapy of diseases in clinic in the future.
出处 《生物化学与生物物理进展》 SCIE CAS CSCD 北大核心 2006年第1期83-86,共4页 Progress In Biochemistry and Biophysics
基金 国家高技术研究发展计划资助项目(863)(2002AA232031)~~
关键词 抗原表位 尿素酶B 抗原性 鉴定 筛选 荧光偏振 antigen epitope, Urease B (UreB), antigenicity, identification, screening,fluorescence polarization(FP)
  • 相关文献

参考文献7

  • 1Hoop J P, Wood K R. Prediction of protein antigenic determinants from amino acid sequences. Immunology, 1981, 78 (6): 3824.
  • 2Kyte J, Doolittle R F. A Simple method for displaying hydropathic character of a protein. J Mol Biol, 1983, 157 (1): 105.
  • 3Tsche H. Modem Methods in Protein and Nucleic Acid Research.Ist. New York: Walterde Gruger Berlin, 1990.231.
  • 4Welling G W, Weijer W J, Vander Z R, et al. Prediction of sequential antigenic regions in proteins. FEBS Lett, 1985, 188(2):215.
  • 5张文红,王琰,郭慧芳,白玉杰,阎小君.用单表位合成肽抗原荧光偏振免疫法检测抗幽门螺旋杆菌尿素酶的抗体[J].细胞与分子免疫学杂志,2005,21(3):371-374. 被引量:3
  • 6Dandliker W B, Kelly R J, Dandliker J, et al. Fluorescence polarization immunoassay. Theory and experimental method.Immunochemistry, 1973, 10 (4): 219-227.
  • 7Mel'nichenko O A, Eremin S A, Egorov A M, et al. Polarized immunofluorescent analysis of the herbicide isoproturon. Vopr Med Khim, 1995, 41 (2): 60-62.

二级参考文献10

  • 1Nasir MS, Jolley ME. The use of fluorescence polarization assays for the detection of infectious diseases[J]. Comb Chem High Throughput Screen, 2003, 6(3): 235 -244.
  • 2Klaus N, Min L, David G, et al. Fluorescence polarization immunoassay: Detection of antibody to brucella abortus [J]. Methods, 2000,22:71 -76.
  • 3Nasir MS, Jolley ME. Fluorescence polarization: an analytical tool for immunoassay and drug discovery [J]. Comb Chem High Throughput Screen, 1999, 2(4): 177 - 190.
  • 4Delchier JC, Lamarque D, Levy M, et al. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type[J]. Am J Gastroenterol, 2001,96(8): 2324 -2328.
  • 5Meyer JM, Silliman NP, Dixon CA, et al. Helicobacter pylori and early duodenal ulcer status post-treatment: a review [J]. Helicobacter,2001, 6(2): 84 -92.
  • 6International Agency for Research on Cancer, World Health Organization. Schistosomes, liver flukes and Helicobacter pylori. IARC working group on the evaluation of carcinogenic risks to humans [C].Monogr Eva. Carcinog Risks Hum, 1994, 61: 218 -220.
  • 7Vandenplas Y.Helicobacter pylori infection[J].World Journal of Gastroenterology,2000,6(1):20-31. 被引量:120
  • 8高志刚,邹全明,郭刚,郭桐生,曾韦锟,解庆华.重组幽门螺杆菌尿素酶B亚单位疫苗鼻腔免疫的实验研究[J].细胞与分子免疫学杂志,2003,19(1):68-70. 被引量:9
  • 9朱森林,陈旻湖,陈洁,焦志勇,李国庆,陈为,彭晓忠,胡品津.优化构建UreB/HpaA双价幽门螺杆菌减毒活菌疫苗的免疫保护作用[J].中华消化杂志,2003,23(10):583-586. 被引量:13
  • 10姜政,黄爱龙,蒲丹,陶小红,王丕龙.人幽门螺杆菌18000外膜蛋白与HspA双价疫苗的构建和表达[J].细胞与分子免疫学杂志,2004,20(1):62-66. 被引量:13

共引文献2

同被引文献53

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部